ClinicalTrials.Veeva

Menu

Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy

M

Mansoura University

Status and phase

Not yet enrolling
Phase 2
Phase 1

Conditions

Laparoscopic Cholecystectomy

Treatments

Drug: Placebo
Drug: Venlafaxine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Recent studies on the impact of perioperative venlafaxine for treatment of acute postoperative pain have yielded positive outcomes . The aim of the present study is to investigate the role of perioperative venlafaxine on the management of postoperative pain in patients undergoing LC.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Patients who are scheduled to undergo elective LC

Exclusion criteria

1- Patients with acute pancreatitis 2. Patients undergoing chronic pain treatment 3. Patients who received analgesics or sedatives 24 h before scheduled surgery 3. Patients had alcohol or drug addiction 4. Severe hepatic and renal dysfunction 5. Previous allergic response to duloxetine 6. Pregnancy and lactation 7. Patients with communication problems, cognitive dysfunction, or psychological disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Laparoscopic Cholecystectomy
Active Comparator group
Treatment:
Drug: Venlafaxine
Control
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems